{"id":31023,"date":"2025-11-07T18:05:42","date_gmt":"2025-11-07T17:05:42","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/"},"modified":"2025-11-14T16:04:02","modified_gmt":"2025-11-14T15:04:02","slug":"dim-one-health-2-0-call-for-projects-2025-investment-2nd-session","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/","title":{"rendered":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session)"},"content":{"rendered":"\n<p>The major areas of interest (DIM), regional research policy measures implemented by the \u00cele-de-France Region, aim to bring together networks of laboratories located in \u00cele-de-France, working in targeted, certified areas. <\/p>\n\n\n\n<p>The objective of DIM One Health 2.0 is therefore to promote innovative fundamental or applied research in the field of One Health, integrating aspects of human health, environmental health and animal health focused on infectious agents and structured around two main areas: <\/p>\n\n\n\n<ol>\n<li><strong>Origin<\/strong>: Causality\/aetiology and assessment of infectious risks<\/li>\n\n\n\n<li><strong>Intervention<\/strong>: proposals for operational solutions<\/li>\n<\/ol>\n\n\n\n<p>The 2025 call for projects will fund:<\/p>\n\n\n\n<p>&#8211; Doctoral and post-doctoral grants and scientific events (operating project)<\/p>\n\n\n\n<p>&#8211; The purchase of scientific research equipment and materials up to 66% of their cost, with the remainder to be provided by the applicant (investment project)<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"589\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\" alt=\"\" class=\"wp-image-31019\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png 1024w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health-300x173.png 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health-768x442.png 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\">\n<p><strong>Find out more and apply before 30 November 2025.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-luminous-vivid-orange-background-color has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/doh2025invest.sciencescall.org\/?lang=fr\">Find out more<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The major areas of interest (DIM), regional research policy measures implemented by the \u00cele-de-France Region, aim to bring together networks of laboratories located in \u00cele-de-France, working in targeted, certified areas. The objective of DIM One Health 2.0 is therefore to promote innovative fundamental or applied research in the field of One Health, integrating aspects of [&hellip;]<\/p>\n","protected":false},"author":275,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[59,58],"tags":[6769,6770],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T17:05:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-14T15:04:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\" \/>\n<meta name=\"author\" content=\"supportmlcom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"supportmlcom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\"},\"author\":{\"name\":\"supportmlcom\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\"},\"headline\":\"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session)\",\"datePublished\":\"2025-11-07T17:05:42+00:00\",\"dateModified\":\"2025-11-14T15:04:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\"},\"wordCount\":144,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\",\"keywords\":[\"Call for Proposals\",\"News\"],\"articleSection\":[\"Calls for projects\",\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\",\"name\":\"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\",\"datePublished\":\"2025-11-07T17:05:42+00:00\",\"dateModified\":\"2025-11-14T15:04:02+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Calls for projects\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\",\"name\":\"supportmlcom\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/","og_locale":"en_GB","og_type":"article","og_title":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2025-11-07T17:05:42+00:00","article_modified_time":"2025-11-14T15:04:02+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png"}],"author":"supportmlcom","twitter_card":"summary_large_image","twitter_misc":{"Written by":"supportmlcom","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/"},"author":{"name":"supportmlcom","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5"},"headline":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session)","datePublished":"2025-11-07T17:05:42+00:00","dateModified":"2025-11-14T15:04:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/"},"wordCount":144,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png","keywords":["Call for Proposals","News"],"articleSection":["Calls for projects","News"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/","name":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session) - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png","datePublished":"2025-11-07T17:05:42+00:00","dateModified":"2025-11-14T15:04:02+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/11\/DIM-1-Health.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/dim-one-health-2-0-call-for-projects-2025-investment-2nd-session\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"Calls for projects","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/"},{"@type":"ListItem","position":4,"name":"DIM One HEALTH 2.0: Call for projects 2025 \u2013 Investment (2nd session)"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5","name":"supportmlcom"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 17:08:47","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/31023"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=31023"}],"version-history":[{"count":5,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/31023\/revisions"}],"predecessor-version":[{"id":31063,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/31023\/revisions\/31063"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=31023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=31023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=31023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}